Cargando…

COVID-19 and Glomerular Diseases

COVID-19 is a systemic disease, and the kidney is one of the target organs of infection. Kidney injury is common and can occur in up to 40% of patients. Several glomerular diseases have been reported in association with COVID-19. Some are likely related to COVID-19 whereas many are likely coincident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klomjit, Nattawat, Zand, Ladan, Cornell, Lynn D., Alexander, Mariam Priya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041821/ https://www.ncbi.nlm.nih.gov/pubmed/37274308 http://dx.doi.org/10.1016/j.ekir.2023.03.016

Ejemplares similares

COVID-19 Vaccination and Glomerulonephritis
por: Klomjit, Nattawat, et al.
Publicado: (2021)

New Onset Glomerular Disease Post–COVID-19 Vaccination: Is There a Link?
por: Radhakrishnan, Yeshwanter, et al.
Publicado: (2023)

Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis
por: Kittanamongkolchai, Wonngarm, et al.
Publicado: (2016)

The Cost-effectiveness of Peritoneal Dialysis Is Superior to Hemodialysis: Updated Evidence From a More Precise Model
por: Klomjit, Nattawat, et al.
Publicado: (2020)

Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)

Relapsing and Remitting Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Association With Infection and Vaccination: A Case Report
por: Moubarak, Simon, et al.
Publicado: (2022)

Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease
por: Nasr, Samih H., et al.
Publicado: (2021)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Glomerular Diseases with Reference to COVID-19
por: Gulati, Sanjeev, et al.
Publicado: (2020)

Current Understanding of Clinical Manifestations of COVID-19 in Glomerular Disease
por: Shimmel, Allison, et al.
Publicado: (2021)

C3 Glomerulonephritis: Clinicopathologic findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up
por: Sethi, Sanjeev, et al.
Publicado: (2012)

Glomerular Disease in Women
por: Wiles, Kate, et al.
Publicado: (2018)

Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor—A Report of 3 Cases
por: Herrmann, Sandra M., et al.
Publicado: (2020)

Impaired immunomodulatory capacity in adipose tissue‐derived mesenchymal stem/stromal cells isolated from obese patients
por: Zhu, Xiang‐Yang, et al.
Publicado: (2021)

Renal Glomerular Diseases
Publicado: (1982)

Kidney Biopsy Findings in Patients With COVID-19, Kidney Injury, and Proteinuria
por: Nasr, Samih H., et al.
Publicado: (2021)

Autoimmunity and Infection in Glomerular Disease
por: Casuscelli, Chiara, et al.
Publicado: (2023)

Complement catalyzing glomerular diseases
por: Zipfel, Peter F., et al.
Publicado: (2021)

Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
por: Yeaman, Michael R.
Publicado: (2021)

De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?
por: Abbas, Fedaey, et al.
Publicado: (2017)

Atypical Anti-Glomerular Basement Membrane Disease
por: Bharati, Joyita, et al.
Publicado: (2023)

Lysosome function in glomerular health and disease
por: Meyer-Schwesinger, Catherine
Publicado: (2021)

Anti–glomerular basement membrane disease during the COVID-19 pandemic
por: Prendecki, Maria, et al.
Publicado: (2020)

Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients
por: Zand, Ladan, et al.
Publicado: (2023)

Glomerular diseases and cancer: evaluation of underlying malignancy
por: Pani, Antonello, et al.
Publicado: (2015)

Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases
por: Li, Guangbi, et al.
Publicado: (2020)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever
por: Siligato, Rossella, et al.
Publicado: (2021)

Critical evaluation of cancer risks in glomerular disease
por: Thet, Zaw, et al.
Publicado: (2022)

The Pathophysiology of H(2)S in Renal Glomerular Diseases
por: Beck, Karl-Friedrich, et al.
Publicado: (2022)

New Insights into Glomerular Parietal Epithelial Cell Activation and Its Signaling Pathways in Glomerular Diseases
por: Su, Hua, et al.
Publicado: (2015)

A patient with COVID-19 and anti-glomerular basement membrane disease
por: Koc, Neriman Sila, et al.
Publicado: (2021)

A patient with COVID-19 and anti-glomerular basement membrane disease
por: Koc, Neriman Sila, et al.
Publicado: (2021)

Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier
por: Satchell, Simon C., et al.
Publicado: (2009)

Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases
por: Sol, Marloes, et al.
Publicado: (2020)

COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
por: Gauckler, Philipp, et al.
Publicado: (2023)

Complement in glomerular injury
por: Berger, Stefan P., et al.
Publicado: (2007)

Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
por: Ge, Mengyuan, et al.
Publicado: (2021)

Glomerular Diseases in Diabetic Patients: Implications for Diagnosis and Management
por: Oliva-Damaso, Nestor, et al.
Publicado: (2021)

Contemporary Monoclonal Antibody Utilization in Glomerular Diseases
por: Mansour, Iyad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_na2gni1e1j03nvh3chf7fofab0